Low-Density Lipoprotein Cholesterol Targeting: A Continued Controversy

被引：1
|
作者：
Whayne, Thomas F., Jr. [1 ]
机构：
[1] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA
来源：
ANGIOLOGY | 2014年 / 65卷 / 03期
关键词：
CORONARY-HEART-DISEASE; COLESTIPOL-NIACIN THERAPY; PARTIAL ILEAL BYPASS; LOWERING TREATMENT; FOLLOW-UP; PREVENTION; REDUCTION; ATHEROSCLEROSIS; STATIN; EVENT;
D O I：
10.1177/0003319713508641
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：263 / 264
页数：2
相关论文
共 50 条
  • [1] Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol
    Moriyama, Kengo
    Takahashi, Eiko
    CLINICAL LABORATORY, 2017, 63 (7-8) : 1179 - 1186
  • [2] Targeting low-density lipoprotein cholesterol with PCSK9 inhibitors
    Scherer, Daniel J.
    Nelson, Adam J.
    Psaltis, Peter J.
    Nicholls, Stephen J.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (08) : 856 - 865
  • [3] Effects on Coronary Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol with Statins
    Jean Ferrières
    American Journal of Cardiovascular Drugs, 2009, 9 : 109 - 115
  • [4] Beyond Low-Density Lipoprotein Cholesterol
    Arsenault, Benoit J.
    Rana, Jamal S.
    Stroes, Erik S. G.
    Despres, Jean-Pierre
    Shah, Prediman K.
    Kastelein, John J. P.
    Wareham, Nicholas J.
    Boekholdt, S. Matthijs
    Khaw, Kay-Tee
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 55 (01) : 35 - 41
  • [5] Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
    Willeit, Peter
    Yeang, Calvin
    Moriarty, Patrick M.
    Tschiderer, Lena
    Varvel, Stephen A.
    McConnell, Joseph P.
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (23):
  • [6] Variability in Low-Density Lipoprotein Cholesterol and Cardiovascular Risk
    Baber, Usman
    Halperin, Jonathan L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (15) : 1549 - 1551
  • [7] Low-Density Lipoprotein Cholesterol Lower Is Totally Better
    Cannon, Christopher P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (17) : 2119 - 2121
  • [8] Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol
    Mohamed, Farzahna
    Mansfield, Brett
    Raal, Frederick J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [9] Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol
    Zheng, Weili
    Chilazi, Michael
    Park, Jihwan
    Sathiyakumar, Vasanth
    Donato, Leslie J.
    Meeusen, Jeffrey W.
    Lazo, Mariana
    Guallar, Eliseo
    Kulkarni, Krishnaji R.
    Jaffe, Allan S.
    Santos, Raul D.
    Toth, Peter P.
    Jones, Steven R.
    Martin, Seth S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (02):
  • [10] Alirocumab for low-density lipoprotein cholesterol lowering
    Roth, Eli M.
    FUTURE CARDIOLOGY, 2019, 15 (01) : 17 - 29
12345